The International Contraceptive Access (ICA) Foundation—a public-private partnership between the Population Council and Bayer HealthCare Pharmaceuticals—commits to donating contraceptive products to public health organizations, such as multilaterals, governments and NGOs in Family Planning 2020 (FP2020) focus countries.

The foundation commits to offering in donation up to 20,000 levonorgestrel releasing intrauterine systems (LNG IUS) per year from 2016 to 2020 to qualified service organizations in the 69 FP2020 focus countries—after approval by the Board of the project proposals LNG IUS is a contraceptive method containing a synthetic female hormone, levonorgestrel, which is released slowly into the uterus (womb), and is widely used in other contraceptive methods, such as implants and oral contraceptive pills.

Over the first year of use, the pregnancy rate for LNG IUS users is less than 1 percent. Since 2003, the ICA Foundation has donated nearly 75,000 LNG IUS devices to organizations in 28 developing countries in an effort to serve the reproductive needs of women and families in resource-poor settings.